Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model ... in prostate cancer cells, leads to increased osteopontin induction, increased extracellular signal-regulated ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.